275 related articles for article (PubMed ID: 7916660)
1. Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Pollak MR; Brown EM; Chou YH; Hebert SC; Marx SJ; Steinmann B; Levi T; Seidman CE; Seidman JG
Cell; 1993 Dec; 75(7):1297-303. PubMed ID: 7916660
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
[TBL] [Abstract][Full Text] [Related]
3. Stepwise CaSR, AP2S1, and GNA11 sequencing in patients with suspected familial hypocalciuric hypercalcemia.
Szalat A; Shpitzen S; Tsur A; Zalmon Koren I; Shilo S; Tripto-Shkolnik L; Durst R; Leitersdorf E; Meiner V
Endocrine; 2017 Mar; 55(3):741-747. PubMed ID: 28176280
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
[TBL] [Abstract][Full Text] [Related]
5. Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca
Goolam MA; Brown AP; Edwards KT; Gregory KJ; Leach K; Conigrave AD
J Bone Miner Res; 2022 Sep; 37(9):1787-1807. PubMed ID: 35848051
[TBL] [Abstract][Full Text] [Related]
6. Disorders of the Calcium Sensing Signaling Pathway: From Familial Hypocalciuric Hypercalcemia (FHH) to Life Threatening Conditions in Infancy.
Höppner J; Sinningen K; Raimann A; Obermayer-Pietsch B; Grasemann C
J Clin Med; 2022 May; 11(9):. PubMed ID: 35566721
[TBL] [Abstract][Full Text] [Related]
7. [Disorders Caused by Mutations in Calcium-Sensing Receptor and Related Diseases.].
Michigami T
Clin Calcium; 2017; 27(4):521-527. PubMed ID: 28336828
[TBL] [Abstract][Full Text] [Related]
8. A novel case of neonatal severe hyperparathyroidism successfully treated with a type II calcimimetic drug.
Leunbach TL; Hansen AT; Madsen M; Cipliene R; Christensen PS; Schou AJ
Bone Rep; 2021 Jun; 14():100761. PubMed ID: 33748353
[TBL] [Abstract][Full Text] [Related]
9. [Syndrome of hypocalсiuric hypercalcemia. Is it rare? Two clinical cases in an outpatient clinic].
Sviridonova MA
Probl Endokrinol (Mosk); 2022 Jun; 68(5):24-31. PubMed ID: 36337015
[TBL] [Abstract][Full Text] [Related]
10. Functional Assessment of Calcium-Sensing Receptor Variants Confirms Familial Hypocalciuric Hypercalcemia.
Mullin BH; Pavlos NJ; Brown SJ; Walsh JP; McKellar RA; Wilson SG; Ward BK
J Endocr Soc; 2022 May; 6(5):bvac025. PubMed ID: 35356007
[TBL] [Abstract][Full Text] [Related]
11. Familial hypocalciuric hypercalcemia type 1 due to a novel homozygous mutation of the calcium-sensing receptor gene.
Borsari S; Marcocci C; Cetani F
J Endocrinol Invest; 2017 Nov; 40(11):1271-1272. PubMed ID: 28620806
[No Abstract] [Full Text] [Related]
12. Familial hypocalciuric hypercalcemia presenting with psychosis.
Shaw-Jones M; Short B
QJM; 2022 Nov; 115(11):763-764. PubMed ID: 35789394
[No Abstract] [Full Text] [Related]
13. Making (mis) sense of asymptomatic marked hypercalcemia in pregnancy.
Maltese G; Izatt L; McGowan BM; Hafeez K; Hubbard JG; Carroll PV
Clin Case Rep; 2017 Oct; 5(10):1587-1590. PubMed ID: 29026550
[TBL] [Abstract][Full Text] [Related]
14. New mutation in the calcium-sensing receptor gene as a form of presentation of familial hypocalciuric hypercalcemia type 1.
Rojo Álvaro J; Larrañaga Unanue I; Bilbao Garay I
Med Clin (Barc); 2023 Dec; 161(12):552-553. PubMed ID: 37541942
[No Abstract] [Full Text] [Related]
15. The Importance of Functionally Characterizing Calcium-Sensing Receptor Variants in Individuals With Hypercalcemia.
Gorvin CM
J Endocr Soc; 2022 Jun; 6(6):bvac052. PubMed ID: 35506149
[No Abstract] [Full Text] [Related]
16. Editorial: Physiology and Pathophysiology of the Extracellular Calcium-Sensing Receptor.
Kallay E
Front Physiol; 2018; 9():413. PubMed ID: 29867518
[No Abstract] [Full Text] [Related]
17. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid.
Brown EM; Gamba G; Riccardi D; Lombardi M; Butters R; Kifor O; Sun A; Hediger MA; Lytton J; Hebert SC
Nature; 1993 Dec; 366(6455):575-80. PubMed ID: 8255296
[TBL] [Abstract][Full Text] [Related]
18. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype.
Pollak MR; Chou YH; Marx SJ; Steinmann B; Cole DE; Brandi ML; Papapoulos SE; Menko FH; Hendy GN; Brown EM
J Clin Invest; 1994 Mar; 93(3):1108-12. PubMed ID: 8132750
[TBL] [Abstract][Full Text] [Related]
19. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism.
Pearce SH; Trump D; Wooding C; Besser GM; Chew SL; Grant DB; Heath DA; Hughes IA; Paterson CR; Whyte MP
J Clin Invest; 1995 Dec; 96(6):2683-92. PubMed ID: 8675635
[TBL] [Abstract][Full Text] [Related]
20. Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity.
Heath H; Jackson CE; Otterud B; Leppert MF
Am J Hum Genet; 1993 Jul; 53(1):193-200. PubMed ID: 8317484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
